Jiang Miao, Hughes Danny R, Duszak Richard
Harvey L. Neiman Health Policy Institute, Reston, Virginia; Department of Health Administration and Policy, George Mason University, Fairfax, Virginia.
Harvey L. Neiman Health Policy Institute, Reston, Virginia; Department of Health Administration and Policy, George Mason University, Fairfax, Virginia.
Womens Health Issues. 2015 May-Jun;25(3):239-45. doi: 10.1016/j.whi.2015.03.002.
We sought to examine longitudinal trends in screening mammography utilization and the presence of any changes in utilization associated with the 2009 U.S. Preventive Services Task Force (USPSTF) guideline change.
We use 2005 through 2012 Medicare fee-for-service claims data for a 5% sample of randomly selected beneficiaries. The primary outcome is monthly mammography rate per 1,000 women. Two comparison outcomes are monthly Papanicolaou test rate and monthly routine eye examination rate. The statistical approach is interrupted time series with segmented regression analysis and nonequivalent dependent variables.
Among women age 65 and 90, monthly screening mammography rates were significantly increasing before the 2009 USPSTF guideline change. Immediately after the guidelines, there was a significant drop of 1.76 per 1,000 women (p < .001). Three years after the guideline, and after the initial decrease, there was no significant change in rate for those aged 65 to 74, but a continued and significant decline for those aged 75 and older. Two other preventive services (Papanicolaou test and routine eye examinations) did not show any shift associated with the pre- and post-guideline window.
The 2009 revision of USPSTF guidelines on breast cancer was associated with an immediate and significant decrease in screening mammography rates. The long-term impact of the guideline change differs by age and race and may not be fully quantifiable for years after its implementation.
我们试图研究乳腺钼靶筛查利用率的纵向趋势,以及与2009年美国预防服务工作组(USPSTF)指南变更相关的利用率变化情况。
我们使用了2005年至2012年医疗保险按服务收费索赔数据,该数据来自随机抽取的5%受益人的样本。主要结果是每1000名女性的月度乳腺钼靶检查率。另外两个比较结果是月度巴氏试验率和月度常规眼部检查率。统计方法是采用分段回归分析和非等效因变量的中断时间序列分析。
在65岁至90岁的女性中,2009年USPSTF指南变更前,月度乳腺钼靶筛查率显著上升。指南发布后,每1000名女性的筛查率立即显著下降了1.76(p < .001)。指南发布三年后,在最初下降之后,65岁至74岁人群的筛查率没有显著变化,但75岁及以上人群的筛查率持续显著下降。另外两项预防服务(巴氏试验和常规眼部检查)在指南前后没有显示出任何变化。
2009年USPSTF乳腺癌指南修订与乳腺钼靶筛查率立即显著下降有关。指南变更的长期影响因年龄和种族而异,在实施多年后可能无法完全量化。